Guru Ownership Trend
Guru Analysis for Cogent Biosciences, Inc. (COGT)
Cogent Biosciences, Inc. (COGT), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $145.62 M.
Top institutional holders include Stanley Druckenmiller and Steven Cohen.
Institutional sentiment is currently Bullish. This is evidenced by a $49.2 M net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 195.8%. Conversely, Ken Fisher reduced exposure by 53.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Cogent Biosciences, Inc. (COGT)
Major holders include Stanley Druckenmiller ($78.66 M), Steven Cohen ($29.39 M), Renaissance Technologies (RenTech) ($24.48 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 4.14 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $49.2 M, with 5 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited COGT. The total reported sell value was $16.55 M.
Yes, 2 managers opened new positions in COGT, and 3 increased their existing holdings. The total reported buy value was $65.75 M.
